Ane Uranga
Instituto Politécnico Nacional
40 Papers
111 Citations
Ane Uranga is an academic researcher from Instituto Politécnico Nacional. The author has contributed to research in topics: Medicine & Pneumonia. The author has an hindex of 10, co-authored 25 publications.
Chat about Author
Papers
Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Ane Uranga,Pedro Pablo España,Amaia Bilbao,José M. Quintana,Ignacio Arriaga,Maider Intxausti,José Luis Lobo,Laura Tomás,Jesus Camino,Juan Núñez,Alberto Capelastegui +10 more
TL;DR: The Infectious Diseases Society of America/American Thoracic Society recommendations for duration of antibiotic treatment based on clinical stability criteria can be safely implemented in hospitalized patients with CAP.
Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia
Pedro Pablo España,Alberto Capelastegui,Carmen Mar,Amaia Bilbao,José M. Quintana,Rosa Diez,Cristóbal Esteban,Edurne Bereciartua,Unai Unanue,Ane Uranga +9 more
TL;DR: A new risk score combining SCAP score with pro-ADM level is useful to classify severity risk in CAP patients and hence supporting decision-making on hospital admission.
49
Q Fever (Coxiella Burnetii)
TL;DR: Q fever is a zoonotic infectious disease caused by the Coxiella burnetii bacterium that proliferates exclusively in an acidified medium, forming a lysosome-like vacuole and presents a peculiar phenomenon called "antigenic phase variation."
46
Neumonía adquirida en la comunidad. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
Rosario Menéndez,Catia Cilloniz,Pedro Pablo España,Jordi Almirall,Ane Uranga,Raúl Méndez,David Rigau,Antoni Torres +7 more
TL;DR: The etiological source of the infection should be investigated in hospitalized patients who have suspected resistance or who fail to respond to treatment, and the indication of the 13-valent conjugate vaccine in immunocompetent patients with risk factors and comorbidity is reviewed.
40
The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.
Rosario Menéndez,Pedro Pablo España,Emilio Pérez-Trallero,Ane Uranga,Raúl Méndez,Catia Cilloniz,José María Marimón,Isabel Cifuentes,Cristina Méndez,Antoni Torres +9 more
TL;DR: Serotypes included in PCV13 caused a significant proportion of CAP in adults with underlying conditions and in healthy adults, with no significant changes in cases due to PCV7 orPCV13 from 2011 to 2014, suggesting an insufficient indirect protection from childhood vaccination.
28